{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:56:44Z","timestamp":1792727804090,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","award":["KAW 2020.0182"],"award-info":[{"award-number":["KAW 2020.0182"]}],"id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2017-05631"],"award-info":[{"award-number":["2017-05631"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2020-03731"],"award-info":[{"award-number":["2020-03731"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001862","name":"Svenska Forskningsr\u00e5det Formas","doi-asserted-by":"publisher","award":["2018-00924"],"award-info":[{"award-number":["2018-00924"]}],"id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["722729"],"award-info":[{"award-number":["722729"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001729","name":"Stiftelsen f\u00f6r\u00a0Strategisk Forskning","doi-asserted-by":"publisher","award":["FID15-0010"],"award-info":[{"award-number":["FID15-0010"]}],"id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The emergence and continued global spread of the current COVID-19 pandemic has highlighted the need for methods to identify novel or repurposed therapeutic drugs in a fast and effective way. Despite the availability of methods for the discovery of antiviral drugs, the majority tend to focus on the effects of such drugs on a given virus, its constituent proteins, or enzymatic activity, often neglecting the consequences on host cells. This may lead to partial assessment of the efficacy of the tested anti-viral compounds, as potential toxicity impacting the overall physiology of host cells may mask the effects of both viral infection and drug candidates. Here we present a method able to assess the general health of host cells based on morphological profiling, for untargeted phenotypic drug screening against viral infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We combine Cell Painting with antibody-based detection of viral infection in a single assay. We designed an image analysis pipeline for segmentation and classification of virus-infected and non-infected cells, followed by extraction of morphological properties. We show that this methodology can successfully capture virus-induced phenotypic signatures of MRC-5 human lung fibroblasts infected with human coronavirus 229E (CoV-229E). Moreover, we demonstrate that our method can be used in phenotypic drug screening using a panel of nine host- and virus-targeting antivirals. Treatment with effective antiviral compounds reversed the morphological profile of the host cells towards a non-infected state.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The phenomics approach presented here, which makes use of a modified Cell Painting protocol by incorporating an anti-virus antibody stain, can be used for the unbiased morphological profiling of virus infection on host cells. The method can identify antiviral reference compounds, as well as novel antivirals, demonstrating its suitability to be implemented as a strategy for antiviral drug repurposing and drug discovery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12915-021-01086-1","type":"journal-article","created":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T19:03:25Z","timestamp":1627844605000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["A phenomics approach for antiviral drug discovery"],"prefix":"10.1186","volume":"19","author":[{"given":"Jonne","family":"Rietdijk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Tampere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Pettke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina","family":"Georgiev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maris","family":"Lapins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika","family":"Warpman-Berglund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Spjuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjo-Riitta","family":"Puumalainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7671-3707","authenticated-orcid":false,"given":"Jordi","family":"Carreras-Puigvert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,2]]},"reference":[{"key":"1086_CR1","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1126\/science.1187816","volume":"328","author":"JD Bloom","year":"2010","unstructured":"Bloom JD, Gong LI, Baltimore D. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science. 2010;328:1272\u20135.","journal-title":"Science."},{"key":"1086_CR2","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1038\/ncomms3854","volume":"4","author":"R Hai","year":"2013","unstructured":"Hai R, Schmolke M, Leyva-Grado VH, Thangavel RR, Margine I, Jaffe EL, et al. Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility. Nat Commun. 2013;4:2854.","journal-title":"Nat Commun."},{"key":"1086_CR3","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.abf9302","volume":"371","author":"TN Starr","year":"2021","unstructured":"Starr TN, Greaney AJ, Addetia A, Hannon WW, Choudhary MC, Dingens AS, et al. Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. Science. 2021;371:850\u20134.","journal-title":"Science."},{"key":"1086_CR4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.copbio.2016.04.003","volume":"39","author":"JC Caicedo","year":"2016","unstructured":"Caicedo JC, Singh S, Carpenter AE. Applications in image-based profiling of perturbations. Curr Opin Biotechnol. 2016;39:134\u201342.","journal-title":"Curr Opin Biotechnol."},{"key":"1086_CR5","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1038\/nprot.2016.105","volume":"11","author":"M-A Bray","year":"2016","unstructured":"Bray M-A, Singh S, Han H, Davis CT, Borgeson B, Hartland C, et al. Cell Painting, a high-content image-based assay for morphological profiling using multiplexed fluorescent dyes. Nat Protoc. 2016;11:1757\u201374.","journal-title":"Nat Protoc."},{"key":"1086_CR6","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nmeth.4397","volume":"14","author":"JC Caicedo","year":"2017","unstructured":"Caicedo JC, Cooper S, Heigwer F, Warchal S, Qiu P, Molnar C, et al. Data-analysis strategies for image-based cell profiling. Nat Methods. 2017;14:849\u201363.","journal-title":"Nat Methods."},{"key":"1086_CR7","doi-asserted-by":"publisher","first-page":"114876","DOI":"10.1016\/j.taap.2019.114876","volume":"389","author":"J Nyffeler","year":"2020","unstructured":"Nyffeler J, Willis C, Lougee R, Richard A, Paul-Friedman K, Harrill JA. Bioactivity screening of environmental chemicals using imaging-based high-throughput phenotypic profiling. Toxicol Appl Pharmacol. 2020;389:114876.","journal-title":"Toxicol Appl Pharmacol."},{"key":"1086_CR8","doi-asserted-by":"crossref","unstructured":"Schiff L, Migliori B, Chen Y, Carter D, Bonilla C, Hall J, et al. Deep learning and automated Cell Painting reveal Parkinson\u2019s disease-specific signatures in primary patient fibroblasts. bioRxiv. 2020;:2020.11.13.380576.","DOI":"10.1101\/2020.11.13.380576"},{"key":"1086_CR9","doi-asserted-by":"publisher","first-page":"14715","DOI":"10.1002\/anie.201907853","volume":"58","author":"A Christoforow","year":"2019","unstructured":"Christoforow A, Wilke J, Binici A, Pahl A, Ostermann C, Sievers S, et al. Design, synthesis, and phenotypic profiling of pyrano-furo-pyridone pseudo natural products. Angew Chem Int Ed. 2019;58:14715\u201323.","journal-title":"Angew Chem Int Ed."},{"key":"1086_CR10","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/2472555218818756","volume":"24","author":"A Kensert","year":"2019","unstructured":"Kensert A, Harrison PJ, Spjuth O. Transfer learning with deep convolutional neural networks for classifying cellular morphological changes. SLAS Discov Adv Life Sci R D. 2019;24:466\u201375.","journal-title":"SLAS Discov Adv Life Sci R D."},{"key":"1086_CR11","doi-asserted-by":"crossref","unstructured":"Way GP, Kost-Alimova M, Shibue T, Harrington WF, Gill S, Piccioni F, Becker T, Shafqat-Abbasi H, Hahn WC, Carpenter AE, Vazquez F, Singh S. Predicting cell health phenotypes using image-based morphology profiling. Mol Biol Cell. 2021;19;32(9):995\u20131005. Epub 2021 Feb 3. PMID: 33534641.","DOI":"10.1091\/mbc.E20-12-0784"},{"key":"1086_CR12","doi-asserted-by":"publisher","first-page":"115209","DOI":"10.1016\/j.bmc.2019.115209","volume":"28","author":"SJ Warchal","year":"2020","unstructured":"Warchal SJ, Dawson JC, Shepherd E, Munro AF, Hughes RE, Makda A, et al. High content phenotypic screening identifies serotonin receptor modulators with selective activity upon breast cancer cell cycle and cytokine signaling pathways. Bioorg Med Chem. 2020;28:115209.","journal-title":"Bioorg Med Chem."},{"key":"1086_CR13","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.pt.2019.05.004","volume":"35","author":"N Aulner","year":"2019","unstructured":"Aulner N, Danckaert A, Ihm J, Shum D, Shorte SL. Next-generation phenotypic screening in early drug discovery for infectious diseases. Trends Parasitol. 2019;35:559\u201370.","journal-title":"Trends Parasitol."},{"key":"1086_CR14","doi-asserted-by":"crossref","unstructured":"Heiser K, McLean PF, Davis CT, Fogelson B, Gordon HB, Jacobson P, et al. Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2. bioRxiv. 2020;2020.04.21.054387.","DOI":"10.1101\/2020.04.21.054387"},{"key":"1086_CR15","doi-asserted-by":"crossref","unstructured":"Mirabelli C, Wotring JW, Zhang CJ, McCarty SM, Fursmidt R, Kadambi NS, et al. Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19. bioRxiv. 2020;2020.05.27.117184.","DOI":"10.1101\/2020.05.27.117184"},{"key":"1086_CR16","doi-asserted-by":"publisher","first-page":"4938","DOI":"10.1038\/s41467-020-18764-3","volume":"11","author":"D Olagnier","year":"2020","unstructured":"Olagnier D, Farahani E, Thyrsted J, Blay-Cadanet J, Herengt A, Idorn M, et al. SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate. Nat Commun. 2020;11:4938.","journal-title":"Nat Commun."},{"key":"1086_CR17","doi-asserted-by":"publisher","first-page":"104988","DOI":"10.1016\/j.antiviral.2020.104988","volume":"185","author":"EB Svenningsen","year":"2021","unstructured":"Svenningsen EB, Thyrsted J, Blay-Cadanet J, Liu H, Lin S, Moyano-Villameriel J, et al. Ionophore antibiotic X-206 is a potent inhibitor of SARS-CoV-2 infection in vitro. Antiviral Res. 2021;185:104988.","journal-title":"Antiviral Res."},{"key":"1086_CR18","doi-asserted-by":"publisher","first-page":"e0194880","DOI":"10.1371\/journal.pone.0194880","volume":"13","author":"E Postnikova","year":"2018","unstructured":"Postnikova E, Cong Y, DeWald LE, Dyall J, Yu S, Hart BJ, et al. Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs. Plos One. 2018;13:e0194880.","journal-title":"Plos One."},{"key":"1086_CR19","doi-asserted-by":"publisher","first-page":"e00725","DOI":"10.1128\/AAC.00725-18","volume":"62","author":"JA Bernatchez","year":"2018","unstructured":"Bernatchez JA, Yang Z, Coste M, Li J, Beck S, Liu Y, et al. Development and validation of a phenotypic high-content imaging assay for assessing the antiviral activity of small-molecule inhibitors targeting Zika virus. Antimicrob Agents Chemother. 2018;62:e00725\u201318.","journal-title":"Antimicrob Agents Chemother."},{"key":"1086_CR20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.stem.2017.06.017","volume":"21","author":"T Zhou","year":"2017","unstructured":"Zhou T, Tan L, Cederquist GY, Fan Y, Hartley BJ, Mukherjee S, et al. High-content screening in hPSC-neural progenitors identifies drug candidates that inhibit Zika virus infection in fetal-like organoids and adult brain. Cell Stem Cell. 2017;21:274\u2013283.e5.","journal-title":"Cell Stem Cell"},{"key":"1086_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41586-020-2577-1","volume":"586","author":"L Riva","year":"2020","unstructured":"Riva L, Yuan S, Yin X, Martin-Sancho L, Matsunaga N, Pache L, et al. Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature. 2020;586:113\u20139.","journal-title":"Nature."},{"key":"1086_CR22","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.chom.2016.07.004","volume":"20","author":"NJ Barrows","year":"2016","unstructured":"Barrows NJ, Campos RK, Powell ST, Prasanth KR, Schott-Lerner G, Soto-Acosta R, et al. A screen of FDA-approved drugs for inhibitors of Zika virus infection. Cell Host Microbe. 2016;20:259\u201370.","journal-title":"Cell Host Microbe."},{"key":"1086_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1089\/adt.2016.730","volume":"14","author":"SJ Warchal","year":"2016","unstructured":"Warchal SJ, Dawson JC, Carragher NO. Development of the theta comparative cell scoring method to quantify diverse phenotypic responses between distinct cell types. ASSAY Drug Dev Technol. 2016;14:395\u2013406.","journal-title":"ASSAY Drug Dev Technol."},{"key":"1086_CR24","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1177\/2472555220928004","volume":"25","author":"C Willis","year":"2020","unstructured":"Willis C, Nyffeler J, Harrill J. Phenotypic profiling of reference chemicals across biologically diverse cell types using the Cell Painting assay. SLAS Discov Adv Sci Drug Discov. 2020;25:755\u201369.","journal-title":"SLAS Discov Adv Sci Drug Discov."},{"key":"1086_CR25","doi-asserted-by":"publisher","first-page":"e80999","DOI":"10.1371\/journal.pone.0080999","volume":"8","author":"SM Gustafsdottir","year":"2013","unstructured":"Gustafsdottir SM, Ljosa V, Sokolnicki KL, Anthony Wilson J, Walpita D, Kemp MM, et al. Multiplex cytological profiling assay to measure diverse cellular states. PLoS ONE. 2013;8:e80999.","journal-title":"PLoS ONE."},{"key":"1086_CR26","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/jmv.10499","volume":"71","author":"ML Ng","year":"2003","unstructured":"Ng ML, Tan SH, See EE, Ooi EE, Ling AE. Early events of SARS coronavirus infection in vero cells. J Med Virol. 2003;71:323\u201331.","journal-title":"J Med Virol."},{"key":"1086_CR27","doi-asserted-by":"publisher","first-page":"10112","DOI":"10.1128\/JVI.01001-12","volume":"86","author":"M Schneider","year":"2012","unstructured":"Schneider M, Ackermann K, Stuart M, Wex C, Protzer U, Sch\u00e4tzl HM, et al. Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-Calpain. J Virol. 2012;86:10112\u201322.","journal-title":"J Virol."},{"key":"1086_CR28","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1126\/science.aar8048","volume":"362","author":"T Visnes","year":"2018","unstructured":"Visnes T, C\u00e1zares-K\u00f6rner A, Hao W, Wallner O, Masuyer G, Loseva O, et al. Small-molecule inhibitor of OGG1 suppresses proinflammatory gene expression and inflammation. Science. 2018;362:834\u20139.","journal-title":"Science."},{"key":"1086_CR29","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.3390\/v12121423","volume":"12","author":"M Tampere","year":"2020","unstructured":"Tampere M, Pettke A, Salata C, Wallner O, Koolmeister T, Cazares-K\u00f6rner A, et al. Novel broad-spectrum antiviral inhibitors targeting host factors essential for replication of pathogenic RNA viruses. Viruses. 2020;12:1423.","journal-title":"Viruses."},{"key":"1086_CR30","doi-asserted-by":"publisher","first-page":"5927","DOI":"10.1128\/JVI.02501-05","volume":"80","author":"EJ Snijder","year":"2006","unstructured":"Snijder EJ, van der Meer Y, Zevenhoven-Dobbe J, Onderwater JJM, van der Meulen J, Koerten HK, et al. Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex. J Virol. 2006;80:5927\u201340.","journal-title":"J Virol."},{"key":"1086_CR31","doi-asserted-by":"crossref","unstructured":"Fung TS, Liu DX. Coronavirus infection, ER stress, apoptosis and innate immunity. Front Microbiol. 2014;5:296.","DOI":"10.3389\/fmicb.2014.00296"},{"key":"1086_CR32","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.virol.2009.12.020","volume":"399","author":"G Ritchie","year":"2010","unstructured":"Ritchie G, Harvey DJ, Feldmann F, Stroeher U, Feldmann H, Royle L, et al. Identification of N-linked carbohydrates from severe acute respiratory syndrome (SARS) spike glycoprotein. Virology. 2010;399:257\u201369.","journal-title":"Virology."},{"key":"1086_CR33","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.biotechadv.2017.12.016","volume":"36","author":"M Rumlov\u00e1","year":"2018","unstructured":"Rumlov\u00e1 M, Ruml T. In vitro methods for testing antiviral drugs. Biotechnol Adv. 2018;36:557\u201376.","journal-title":"Biotechnol Adv."},{"key":"1086_CR34","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271\u2013280.e8.","journal-title":"Cell"},{"key":"1086_CR35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"M Wang","year":"2020","unstructured":"Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30:269\u201371.","journal-title":"Cell Res."},{"key":"1086_CR36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.antiviral.2015.01.011","volume":"116","author":"Y Zhou","year":"2015","unstructured":"Zhou Y, Vedantham P, Lu K, Agudelo J, Carrion R, Nunneley JW, et al. Protease inhibitors targeting coronavirus and filovirus entry. Antiviral Res. 2015;116:76\u201384.","journal-title":"Antiviral Res."},{"key":"1086_CR37","doi-asserted-by":"publisher","first-page":"11876","DOI":"10.1073\/pnas.0505577102","volume":"102","author":"G Simmons","year":"2005","unstructured":"Simmons G, Gosalia DN, Rennekamp AJ, Reeves JD, Diamond SL, Bates P. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci. 2005;102:11876\u201381.","journal-title":"Proc Natl Acad Sci."},{"key":"1086_CR38","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1128\/JVI.01933-08","volume":"83","author":"M Kawase","year":"2009","unstructured":"Kawase M, Shirato K, Matsuyama S, Taguchi F. Protease-mediated entry via the endosome of human coronavirus 229E. J Virol. 2009;83:712\u201321.","journal-title":"J Virol."},{"key":"1086_CR39","doi-asserted-by":"publisher","first-page":"12552","DOI":"10.1128\/JVI.01890-13","volume":"87","author":"K Shirato","year":"2013","unstructured":"Shirato K, Kawase M, Matsuyama S. Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2. J Virol. 2013;87:12552\u201361.","journal-title":"J Virol."},{"key":"1086_CR40","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1002\/cbic.202000381","volume":"21","author":"T Schneidewind","year":"2020","unstructured":"Schneidewind T, Brause A, Pahl A, Burhop A, Mejuch T, Sievers S, et al. Morphological profiling identifies a common mode of action for small molecules with different targets. ChemBioChem. 2020;21:3197\u2013207.","journal-title":"ChemBioChem."},{"key":"1086_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/978-1-4939-8891-4_6","volume-title":"Systems Chemical Biology","author":"A Pahl","year":"2019","unstructured":"Pahl A, Sievers S. The Cell Painting assay as a screening tool for the discovery of bioactivities in new chemical matter. In: Ziegler S, Waldmann H, editors. Systems Chemical Biology. New York: Springer New York; 2019. p. 115\u201326. https:\/\/doi.org\/10.1007\/978-1-4939-8891-4_6."},{"key":"1086_CR42","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1021\/acs.chemrestox.0c00303","volume":"34","author":"S Seal","year":"2021","unstructured":"Seal S, Yang H, Vollmers L, Bender A. Comparison of cellular morphological descriptors and molecular fingerprints for the prediction of cytotoxicity- and proliferation-related assays. Chem Res Toxicol. 2021;34:422\u201337.","journal-title":"Chem Res Toxicol."},{"key":"1086_CR43","doi-asserted-by":"crossref","unstructured":"Becker T, Yang K, Caicedo JC, Wagner BK, Dancik V, Clemons P, et al. Predicting compound activity from phenotypic profiles and chemical structures. bioRxiv. 2020;2020.12.15.422887.","DOI":"10.1101\/2020.12.15.422887"},{"key":"1086_CR44","doi-asserted-by":"publisher","first-page":"107940","DOI":"10.1016\/j.celrep.2020.107940","volume":"32","author":"AJ Pruijssers","year":"2020","unstructured":"Pruijssers AJ, George AS, Sch\u00e4fer A, Leist SR, Gralinksi LE, Dinnon KH, et al. Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice. Cell Rep. 2020;32:107940.","journal-title":"Cell Rep."},{"key":"1086_CR45","doi-asserted-by":"publisher","first-page":"e64508","DOI":"10.7554\/eLife.64508","volume":"10","author":"AZ Mykytyn","year":"2021","unstructured":"Mykytyn AZ, Breugem TI, Riesebosch S, Schipper D, van den Doel PB, Rottier RJ, et al. SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site. eLife. 2021;10:e64508.","journal-title":"eLife."},{"key":"1086_CR46","doi-asserted-by":"publisher","first-page":"e2005970","DOI":"10.1371\/journal.pbio.2005970","volume":"16","author":"C McQuin","year":"2018","unstructured":"McQuin C, Goodman A, Chernyshev V, Kamentsky L, Cimini BA, Karhohs KW, et al. CellProfiler 3.0: Next-generation image processing for biology. Plos Biol. 2018;16:e2005970.","journal-title":"Plos Biol."}],"container-title":["BMC Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12915-021-01086-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12915-021-01086-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12915-021-01086-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T21:57:21Z","timestamp":1672955841000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiol.biomedcentral.com\/articles\/10.1186\/s12915-021-01086-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,2]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1086"],"URL":"https:\/\/doi.org\/10.1186\/s12915-021-01086-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.01.13.423947","asserted-by":"object"}]},"ISSN":["1741-7007"],"issn-type":[{"value":"1741-7007","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,2]]},"assertion":[{"value":"10 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"156"}}